Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys…

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Business man marking buy on board and underlining it.

Image Source: Getty Images

BHP Group Ltd (ASX: BHP)

According to a note out of Morgans, its analysts have retained their add rating but trimmed their price target on this mining giant's shares slightly to $47.40. Morgans remains bullish on BHP due to its strong free cash flow generation and low risk profile. It notes that there is less that "can go wrong" relative to its peers. The BHP share price is trading at $40.12 on Monday afternoon.

GQG Partners Inc (ASX: GQG)

Another note out of Morgans reveals that its analysts have retained their add rating but cut their price target on this fund manager's shares to $1.93. This follows the release of a funds under management update that disappointed. Nevertheless, Morgans remains positive. It notes that GQG's investment performance remains strong, its shares are trading at an attractive level, and the weaker Australian dollar could be a boost to its dividend. The GQG share price is fetching $1.45 today.

Monash IVF Group Ltd (ASX: MVF)

Analysts at Bell Potter have initiated coverage on this fertility treatment company's shares with a buy rating and $1.43 price target. According to the note, Bell Potter is positive on Monash IVF's outlook thanks to a combination of new rebates, its regional expansion, and motivated customers. It is expecting this to underpin strong earnings growth through to FY 2025. The Monash IVF share price is trading at 94 cents on Monday.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Cleanaway Waste Management, New Hope Corporation, CSL shares

Let's check out some new ratings on ASX shares today.

Read more »

Three different hands against a blue backdrop signal thumbs up, indicating share price rise on the ASX market
Broker Notes

3 ASX 200 shares to buy and why: Ord Minnett

The top broker explains its buy recommendations on Fortescue, ARB, and Resmed shares.

Read more »

Piggybank with an army helmet and a drone next to it, symbolising a rising DroneShield share price.
Broker Notes

How high will DroneShield shares go? A broker weighs in

While volatile, the signs are good for this company, Canaccord Genuity says.

Read more »

Woman with her hands out to each side on a light blue background.
Broker Notes

Buy, hold, sell: Ramelius Resources, Medibank, Soul Patts shares

Let's take a look at some new ratings from the experts this week.

Read more »

Two colleagues looking at a graph and comparing share prices.
Broker Notes

Guess which ASX 200 share was just hit with a broker downgrade

Bell Potter has turned lukewarm on this popular stock.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

This ASX uranium company is set to surge: Brokers

Despite a project delay this company's shares look cheap, brokers agree.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares UBS has tipped to increase 44% to 76%

Three very different companies to choose from.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Broker Notes

Morgan Stanley just upgraded their CSL share price target

The blood products company is still looking like a good buy.

Read more »